BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21358820)

  • 1. The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA.
    Gilroy KL; Austin CA
    PLoS One; 2011 Feb; 6(2):e14693. PubMed ID: 21358820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
    McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
    Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
    Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
    Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.
    Deweese JE; Burch AM; Burgin AB; Osheroff N
    Biochemistry; 2009 Mar; 48(9):1862-9. PubMed ID: 19222228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
    Dickey JS; Osheroff N
    Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.
    Deweese JE; Guengerich FP; Burgin AB; Osheroff N
    Biochemistry; 2009 Sep; 48(38):8940-7. PubMed ID: 19697956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
    Bender RP; Osheroff N
    Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.
    Seol Y; Gentry AC; Osheroff N; Neuman KC
    J Biol Chem; 2013 May; 288(19):13695-703. PubMed ID: 23508957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.
    Oestergaard VH; Giangiacomo L; Bjergbaek L; Knudsen BR; Andersen AH
    J Biol Chem; 2004 Jul; 279(27):28093-9. PubMed ID: 15123700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinating the two protomer active sites of human topoisomerase IIalpha: nicks as topoisomerase II poisons.
    Deweese JE; Osheroff N
    Biochemistry; 2009 Feb; 48(7):1439-41. PubMed ID: 19166355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct observation of strand passage by DNA-topoisomerase and its limited processivity.
    Yogo K; Ogawa T; Hayashi M; Harada Y; Nishizaka T; Kinosita K
    PLoS One; 2012; 7(4):e34920. PubMed ID: 22496876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-binding activity of rat DNA topoisomerase II α C-terminal domain contributes to efficient DNA catenation in vitro.
    Kawano S; Kato Y; Okada N; Sano K; Tsutsui K; Tsutsui KM; Ikeda S
    J Biochem; 2016 Mar; 159(3):363-9. PubMed ID: 26527691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the human DNA topoisomerase II C-terminal domain on activity.
    Meczes EL; Gilroy KL; West KL; Austin CA
    PLoS One; 2008 Mar; 3(3):e1754. PubMed ID: 18335031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.
    Drwal MN; Marinello J; Manzo SG; Wakelin LP; Capranico G; Griffith R
    PLoS One; 2014; 9(12):e114904. PubMed ID: 25489853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of the D-Ring to the activity of etoposide against human topoisomerase IIα: potential interactions with DNA in the ternary enzyme--drug--DNA complex.
    Pitts SL; Jablonksy MJ; Duca M; Dauzonne D; Monneret C; Arimondo PB; Anklin C; Graves DE; Osheroff N
    Biochemistry; 2011 Jun; 50(22):5058-66. PubMed ID: 21548574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives.
    Sai Krishna AD; Panda G; Kondapi AK
    Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
    Shapiro AB; Austin CA
    Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human topoisomerase IIalpha uses a two-metal-ion mechanism for DNA cleavage.
    Deweese JE; Burgin AB; Osheroff N
    Nucleic Acids Res; 2008 Sep; 36(15):4883-93. PubMed ID: 18653531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.
    McClendon AK; Osheroff N
    Biochemistry; 2006 Mar; 45(9):3040-50. PubMed ID: 16503659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.